| scholarly article | Q13442814 |
| P50 | author | Nelleke A Gruis | Q42392971 |
| Rolando Meloni | Q47504206 | ||
| Julia A Newton Bishop | Q47973102 | ||
| P2093 | author name string | N K Spurr | |
| G Peters | |||
| J Cuzick | |||
| A M Frischauf | |||
| V Bataille | |||
| D T Bishop | |||
| P Selby | |||
| S Brookes | |||
| M Harland | |||
| E Pinney | |||
| P2860 | cites work | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 |
| Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma | Q28270834 | ||
| A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma | Q28296086 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| Mutations and altered expression of p16INK4 in human cancer. | Q35892778 | ||
| Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population | Q37409666 | ||
| Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma | Q40019366 | ||
| Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity | Q42064477 | ||
| Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22 | Q44552643 | ||
| Role of the INK4a locus in tumor suppression and cell mortality. | Q53455197 | ||
| Genetic heterogeneity in familial malignant melanoma | Q56828477 | ||
| Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus | Q57269211 | ||
| Localization of the 9p Melanoma Susceptibility Locus (MLM) to a 2-cM Region between D9S736 and D9S171 | Q57949062 | ||
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 | Q59082348 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2061-2067 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Germline mutations of the CDKN2 gene in UK melanoma families | |
| P478 | volume | 6 |
| Q36808635 | A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). |
| Q35023156 | A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families |
| Q52857972 | A mutation hotspot at the p14ARF splice site. |
| Q35699278 | A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma |
| Q40227530 | A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family |
| Q57499970 | A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families |
| Q34142079 | A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families |
| Q74164931 | Ankyrin for clues about the function of p16INK4a |
| Q28215807 | Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition |
| Q34286570 | Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts |
| Q57391793 | CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma |
| Q36643400 | CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation |
| Q51080278 | CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma. |
| Q39564985 | Classifying variants of CDKN2A using computational and laboratory studies |
| Q45737789 | Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System. |
| Q73867879 | Differential gene expression in leiomyosarcoma |
| Q34093068 | Differentiation therapy of human cancer: basic science and clinical applications |
| Q35541602 | Frequent p16-independent inactivation of p14ARF in human melanoma |
| Q30322978 | Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information. |
| Q30375327 | Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. |
| Q35162369 | Genetic epidemiology of melanoma |
| Q34067607 | Genetics of familial and sporadic melanoma |
| Q40773879 | Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. |
| Q36694476 | Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma |
| Q36499211 | High- and low-penetrance cutaneous melanoma susceptibility genes. |
| Q30360539 | Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). |
| Q52858162 | Intronic sequence variants of the CDKN2A gene in melanoma pedigrees. |
| Q41988898 | Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins |
| Q24649783 | Mutation testing in melanoma families: INK4A, CDK4 and INK4D |
| Q42631112 | Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients |
| Q58024946 | Mutations in theINK4a/ARFMelanoma Susceptibility Locus Functionally Impair p14ARF |
| Q36643968 | No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. |
| Q44279182 | Phosphorylation of p16INK4A correlates with Cdk4 association |
| Q39722414 | Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A. |
| Q52857616 | Prevalence of 9p21 deletions in UK melanoma families. |
| Q33703270 | Role of Epigenetics in Uveal Melanoma |
| Q36615991 | Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours. |
| Q35840024 | Selection criteria for genetic assessment of patients with familial melanoma |
| Q42270133 | Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria |
| Q79435498 | The M53I mutation in CDKN2A is a founder mutation that predominates in melanoma patients with Scottish ancestry |
| Q82520371 | The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma |
| Q36785968 | The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma |
| Q52866201 | The genetics of melanoma: the UK experience. |
| Q54317457 | The p16INK4a/CDKN2A tumor suppressor and its relatives. |
| Q42628813 | Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. |
| Q41984636 | Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations |
| Q100152631 | p16INK4A mutants do not bind CDK4 |
| Q100152628 | p16INK4A mutants do not bind CDK4,CDK6 |
| Q36971412 | p16INK4a-induced senescence is disabled by melanoma-associated mutations |
Search more.